XTRA:FYBBiotechs
Formycon (XTRA:FYB) Stock Can Small Profit Hold Up Against Cash Strain?
Formycon stock closed at €18.56 on Thursday after a choppy few months, with the share price roughly flat over 30 days and slightly weaker over 90 days. The market reaction looks muted compared with what just landed in the earnings. Revenue for Q2 2026 came in at €12.663m and the company swung to a small net profit of €0.372m, helped by a sharp improvement in adjusted earnings before interest, tax, depreciation and amortisation. The key question now is whether traders are underpricing that...